CME on Your Terms – The Osler Institute utilized state of the art equipment to record our Live August 2017 comprehensive Neurology in order to bring it to you!  These Video/Audio files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection. You have access to watch or listen on your phone, tablet or computer. This Video/Audio product offers a learning experience that is almost like being at the live activity itself, but without travel costs and time away from your practice. Included with each Online Review is a downloadable copy of the e-syllabus that corresponds to the Video/Audio lectures for your use while viewing/listening or as a free-standing study guide.

Clear
Accreditation:   The Osler Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation:  The Osler Institute designates this Enduring Material for a maximum of 58 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • Release Date: February 19, 2018
  • Expiration Date: February 18, 2021
  • Estimated Time to Complete: 58 hours
Required Physician Participation:  

Review the audio/video lectures at your own pace. To claim CME credit, Learners must successfully complete a self-assessment post-test (score of 75% or greater is required) and activity evaluation to test knowledge gained and its application to your practice.

  • Unlimited use for 6 months, only $675.00
  • or
  • 1 month for just $295.00

Osler has partnered with JWPlayer to offer streaming content on our website.  Select your subscription term of one or six months, from any of our video pages, and proceed to checkout.  Once checkout is completed, your subscribed to videos will be available from your account on the 'My Videos' page.  You can sign in to your account with the email address and password set up during registration, or those selected during checkout.

Depending on your browser's security settings, you may have to refresh the page after purchasing to access your video.  All videos are accessed via the JWPlayer.

Faculty and Topics

  • Agnieska Ardelt, MD, Ph.D., MBA Associate Professor of Neurology and Surgery University of Chicago
    Intracranial Hypertension, Brain and Spinal Cord Trauma, Encephalopathy and Coma, Acute Ischemic Stroke, Intracranial Hemorrhage

  • Erik Ensrud, MD Assistant Professor of Neurology Oregon Health Sciences University
    Focal Neuropathies, Spine and Spinal Cord, MS and Demyelinating Diseases, Neuromuscular Junction, Anterior Horn Cell, Peripheral Neuropathies, Myopathies

  • Thomas Geller, MD Professor of Child Neurology St. Louis University
    Neurology In The Nursery I and II, Neurologic Disorders of Infancy I and II,  Neuro-Oncology and Paraneoplastic Disorders

  • Molly Gilbert, MD Clinical Assistant Professor of Ophthalmology James A. Lovell FHCC, Chicago, Illinois
    Neuro-Ophthalmology I and II

  • Douglas Gould, Ph.D. Professor of Neuroscience Oakland University 
    Neuroanatomy I Peripheral Nerve, Neuroanatomy II Central Nervous System, Neuroanatomy III Motor, Neuroanatomy IV Sensory, Neuroanatomy V Visual System, Neuroanatomy VI Auditory, Neuroanatomy VII Diencephalon And Limbic Systems

  • Ajay Gupta, MD Associate Professor of Neurology Cleveland Clinic Foundation
    Epilepsy, Sleep and EEG I and II, Epilepsy, Sleep and EEG III and IV, Neurochemistry and Neurotransmitters, Neurocutaneous Disorders, Neurogenetics

  • Charles Marcuccilli, MD, Ph.D. Associate Professor of Pediatrics University of Chicago
    Infections Developmental Disorders, Neurodegenerative Metabolic Disorders, Vertigo and Hearing Loss or Neuro-otology

  • Muhammad Nashatizadeh, MD† Clinical Assistant Professor of Neurology University of Kansas 
    Movement Disorders I (Parkinsonism), Movement Disorders II (Tremor / Myoclonus), Movement Disorders III (Hyperkinetic), Stroke Syndromes, Stoke Prevention (Stoke Risk Reduction), Toxic and Environmental Neurology, Neurocritical Care, Neuroimaging I Diffusion and Perfusion, Neuroimaging II Epilepsy, Neuroimaging III Cranial Nerves, Neuroimaging IV Demyelinating Diseases, Neuroimaging V Spine, Autonomic Disorders

  • Kathy Newell, MD Associate Prof and Director of Neuropathology University of Kansas
    Neuropathology I - III

  • Michael Newton, MD Associate Clinical Prof Emeritus of Psychiatry University of Cincinnati
    Psychopharmacology I and II, Psychotherapy and PSY Miscellaneous Topics, Substance Abuse

  • Simon Ovanessian, MD Chairman, RWJ Barnabas Hospital, Toms River, New Jersey
    Headache Syndromes and Other Pain Disorders, Psychiatric Disorders, Dementia and Ataxia, Aphasia, Apraxia, and Agnosia, 

†Course Program Planning Committee

Faculty, Planner, and Reviewer Disclosure Declaration

In compliance with the Standards, Guidelines, and Ethical opinions of the ACCME, AAMC and AMA, The Osler Institute requires that anyone with input into the planning or presentation of Continuing Medical Education activities provided or jointly-provided by The Osler Institute must disclose to the program audience any relevant financial relationships with companies or organizations about whose products or services they are discussing in their presentations. Copies of the Faculty Disclosure Forms will be available during this program.

  • The following faculty/planners/reviewers disclosed a relevant financial relationship(s).
    • Ajay Gupta, MD - consultant for Malincrodt and Sunovion Pharmaceuticals as well as Elsai, Inc.

    • Simon Ovanessian, MD - speaker for Otsuka Pharmaceutical and Alkermes Co

  • The following faculty/planners/reviewers listed no relevant financial relationship(s) to disclose.
    • Agnieszka Ardelt, MD, PhD, MBA
    • Erik Ensrud, MD
    • Thomas Geller, MD
    • Molly Gilbert, MD
    • Douglas Gould, MD
    • Charles Marcuccilli, MD, PhD
    • Kathy Newell, MD
    • Michael Newton, MD
    • Muhammad Nashatizadeh, MD†*
    • Angie Kowitz†
    • Joseph Selliken, MD†
    • Michael Stewart†
    • Sally Schuette, PhD†
    • Copies of the Faculty Disclosure Forms are available upon request.
      † Program Planning Committee
      * Reviewer if Applicable

Learning Objectives

At the conclusion of this course each participant will be able to:

  • Identify and discuss clinically relevant aspects of neurochemistry, neuroanatomy, neurophysiology, and neuropharmacology
  • Interpret neuroimaging studies
  • Recognize and describe all major neurological disorders and important variants
  • Discuss developmental disorders and scientific underpinnings
  • Distinguish abnormal behavioral and personality changes
  • Describe use of appropriate psychopharmacology agents for all major neurologic disorders and important interactions
  • Identify and plan treatment for alcoholism and substance abuse
  • Identify and distinguish between altered states of consciousness and memory disorders
  • Implement appropriate primary and secondary stroke prevention strategies